These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 9245141)
21. Pulsed-field gel electrophoresis, pertactin, pertussis toxin S1 subunit polymorphisms, and surfaceome analysis of vaccine and clinical Bordetella pertussis strains. Bottero D; Gaillard ME; Fingermann M; Weltman G; Fernández J; Sisti F; Graieb A; Roberts R; Rico O; Ríos G; Regueira M; Binsztein N; Hozbor D Clin Vaccine Immunol; 2007 Nov; 14(11):1490-8. PubMed ID: 17699837 [TBL] [Abstract][Full Text] [Related]
22. Rabbit nasopharyngeal colonization by Bordetella pertussis: the effects of immunization on clearance and on serum and nasal antibody levels. Ashworth LA; Fitzgeorge RB; Irons LI; Morgan CP; Robinson A J Hyg (Lond); 1982 Jun; 88(3):475-86. PubMed ID: 6282959 [TBL] [Abstract][Full Text] [Related]
25. Development of vaccines against pertussis caused by Bordetella holmesii using a mouse intranasal challenge model. Saito M; Odanaka K; Otsuka N; Kamachi K; Watanabe M Microbiol Immunol; 2016 Sep; 60(9):599-608. PubMed ID: 27515393 [TBL] [Abstract][Full Text] [Related]
26. [Relationship of the sensitizing and protective properties of pertussis antigens]. Lebedev VS; Selezneva VP; Moshiashvili IIa; Zakharova NS Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):83-7. PubMed ID: 6285648 [TBL] [Abstract][Full Text] [Related]
27. [Physicochemical and biological characteristics of preparations of an antigenic complex isolated from the cultivation medium of Bordetella pertussis]. Semina IE; Bazhanova IG; Tsvetkova NV; Remova TN; Ozeretskovskaia MN Zh Mikrobiol Epidemiol Immunobiol; 1988 Aug; (8):76-9. PubMed ID: 2904201 [TBL] [Abstract][Full Text] [Related]
29. Disruption of Bordetella pertussis in the Ribi cell fractionator. 1. Effect of different pressures. Hollinger E; Wardlaw AC Can J Microbiol; 1971 Sep; 17(9):1169-74. PubMed ID: 4329814 [No Abstract] [Full Text] [Related]
30. Expression of P.69/pertactin from Bordetella pertussis in a baculovirus/insect cell expression system: protective properties of the recombinant protein. Charles I; Rodgers B; Musgrave S; Peakman TC; Chubb A; Fairweather N; Dougan G; Roberts M Res Microbiol; 1993; 144(9):681-90. PubMed ID: 8190994 [TBL] [Abstract][Full Text] [Related]
31. A recombinant iron transport protein from Bordetella pertussis confers protection against Bordetella parapertussis. Alvarez Hayes J; Oviedo JM; Valdez H; Laborde JM; Maschi F; Ayala M; Shah R; Fernandez Lahore M; Rodriguez ME Microbiol Immunol; 2017 Oct; 61(10):407-415. PubMed ID: 28857261 [TBL] [Abstract][Full Text] [Related]
32. Bordetella Pertussis virulence factors in the continuing evolution of whooping cough vaccines for improved performance. Dorji D; Mooi F; Yantorno O; Deora R; Graham RM; Mukkur TK Med Microbiol Immunol; 2018 Feb; 207(1):3-26. PubMed ID: 29164393 [TBL] [Abstract][Full Text] [Related]
34. [Comparative study of HBP-2 and FGP-1 culture media in the production of Bordetella pertussis by fermentation]. Medina García A; Martín Escobar TA; Reyes ET Salud Publica Mex; 1981; 23(6):575-84. PubMed ID: 6278656 [No Abstract] [Full Text] [Related]
35. Purification of serotype 2 fimbriae of Bordetella pertussis and their identification as a mouse protective antigen. Zhang JM; Cowell JL; Steven AC; Manclark CR Dev Biol Stand; 1985; 61():173-85. PubMed ID: 2872103 [TBL] [Abstract][Full Text] [Related]
36. High prevalence of currently circulating Bordetella pertussis isolates not producing vaccine antigen pertactin in Slovenia. Kastrin T; Barkoff AM; Paragi M; Vitek MG; Mertsola J; He Q Clin Microbiol Infect; 2019 Feb; 25(2):258-260. PubMed ID: 30691616 [No Abstract] [Full Text] [Related]
37. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough. van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847 [TBL] [Abstract][Full Text] [Related]
38. Bordetella pertussis iron regulated proteins as potential vaccine components. Alvarez Hayes J; Erben E; Lamberti Y; Principi G; Maschi F; Ayala M; Rodriguez ME Vaccine; 2013 Aug; 31(35):3543-8. PubMed ID: 23731630 [TBL] [Abstract][Full Text] [Related]
39. Cell-mediated immune response of healthy adults to Bordetella pertussis vaccine antigens. Ausiello CM; Lande R; la Sala A; Urbani F; Cassone A J Infect Dis; 1998 Aug; 178(2):466-70. PubMed ID: 9697728 [TBL] [Abstract][Full Text] [Related]
40. [Properties of an acellular preparation of Bordetella pertussis and its analysis after centrifugation in saccharose gradient]. Letowska I; Kaczurba E; Schiller B Med Dosw Mikrobiol; 1993; 45(3):289-94. PubMed ID: 8189799 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]